Study of DCR-A1AT in Healthy Adult Volunteers

Clinical trial NCT04174118 · COMPLETED

Trial details

NCT number: NCT04174118
Sponsor: Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Alpha 1-Antitrypsin Deficiency

Start date: 2019-10-24
Primary completion: 2021-07-06
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.